Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology
Authors:
- 28 March 2023
- book chapter
- Published by Elsevier
- Vol. 97, 375-422
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (R01 GM1155884)
- National Center for Complementary and Integrative Health (R21 AT010761)
This publication has 185 references indexed in Scilit:
- Mending broken hearts: cardiac development as a basis for adult heart regeneration and repairNature Reviews Molecular Cell Biology, 2013
- A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal developmentProstaglandins & Other Lipid Mediators, 2011
- N-Docosahexaenoylethanolamide promotes development of hippocampal neuronsBiochemical Journal, 2011
- Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female ratsBehavioural Brain Research, 2009
- The emerging role of the endocannabinoid system in cardiovascular diseaseSeminars in Immunopathology, 2009
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentProceedings of the National Academy of Sciences, 2008
- Multiple pathways involved in the biosynthesis of anandamideNeuropharmacology, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and actionBritish Journal of Pharmacology, 2007
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007